Cargando…

Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically

The management of multiple myeloma (MM) is challenging: An assortment of available drug combinations adds complexity to treatment selection, and treatment resistance frequently develops. Given the heterogeneous nature of MM, personalized testing tools are required to identify drug sensitivities. To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giliberto, Mariaserena, Thimiri Govinda Raj, Deepak B., Cremaschi, Andrea, Skånland, Sigrid S., Gade, Alexandra, Tjønnfjord, Geir E., Schjesvold, Fredrik, Munthe, Ludvig A., Taskén, Kjetil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936517/ https://www.ncbi.nlm.nih.gov/pubmed/35148457 http://dx.doi.org/10.1002/1878-0261.13191

Ejemplares similares

P613: ANALYSIS OF EX-VIVO RESPONSE TO SINGLE DRUGS AND DRUG COMBINATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENT SAMPLES
por: Miranda Santana, Leonardo, et al.
Publicado: (2023)

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia
por: Myhrvold, Ida K., et al.
Publicado: (2018)

Cryopreservation of primary B cells minimally influences their signaling responses
por: Hermansen, Johanne U., et al.
Publicado: (2018)

Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines
por: Giliberto, Mariaserena, et al.
Publicado: (2022)

Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies
por: Melvold, Katrine, et al.
Publicado: (2021)

A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine
por: Hermansen, Johanne U., et al.
Publicado: (2023)

Determining drug dose in the era of targeted therapies: playing it (un)safe?
por: Skånland, Sigrid S., et al.
Publicado: (2022)

Standardized assays to monitor drug sensitivity in hematologic cancers
por: Ayuda-Durán, Pilar, et al.
Publicado: (2023)

Functional testing of relapsed chronic lymphocytic leukemia guides precision medicine and maps response and resistance mechanisms. An index case
por: Skånland, Sigrid S., et al.
Publicado: (2022)

Neoplastic plasma cells with Auer rod‐like inclusions
por: Jakob, Nordberg Nørgaard, et al.
Publicado: (2020)

T‐helper cell regulation of CD45 phosphatase activity by galectin‐1 and CD43 governs chronic lymphocytic leukaemia proliferation
por: Imbery, John F., et al.
Publicado: (2022)

Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis
por: Tangen, Jon-Magnus, et al.
Publicado: (2018)

Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice
por: Ruffini, Pier Adelchi, et al.
Publicado: (2014)

Current and Novel Alkylators in Multiple Myeloma
por: Schjesvold, Fredrik, et al.
Publicado: (2021)

bayesynergy: flexible Bayesian modelling of synergistic interaction effects in in vitro drug combination experiments
por: Rønneberg, Leiv, et al.
Publicado: (2021)

Designer nanoparticle: nanobiotechnology tool for cell biology
por: Thimiri Govinda Raj, Deepak B., et al.
Publicado: (2016)

Surface functionalization dependent subcellular localization of Superparamagnetic nanoparticle in plasma membrane and endosome
por: Thimiri Govinda Raj, Deepak B., et al.
Publicado: (2018)

Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependencies
por: Lukas, Marina, et al.
Publicado: (2020)

Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma
por: Kropivsek, Klara, et al.
Publicado: (2023)

How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2014)

Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
por: Raab, Marc S., et al.
Publicado: (2023)

Recent advances in genome annotation and synthetic biology for the development of microbial chassis
por: Hamese, Saltiel, et al.
Publicado: (2023)

Identification of drugs that restore primary cilium expression in cancer cells
por: Khan, Niamat Ali, et al.
Publicado: (2016)

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
por: Schultz, Nina H., et al.
Publicado: (2021)

Springboard to an academic career—A national medical student research program
por: Jacobsen, Geir W., et al.
Publicado: (2018)

USF2 inhibits C/EBP-mediated transcriptional regulation of the RIIβ subunit of cAMP-dependent protein kinase
por: Dahle, Maria Krudtaa, et al.
Publicado: (2002)

PI3K inhibitors in chronic lymphocytic leukemia: where do we go from here?
por: Skånland, Sigrid S., et al.
Publicado: (2022)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia
por: Tjønnfjord, Sara Kristina Viberg, et al.
Publicado: (2021)

Advances in CRISPR-Cas9 for the Baculovirus Vector System: A Systematic Review
por: Sari-Ak, Duygu, et al.
Publicado: (2022)

Anchored PKA as a gatekeeper for gap junctions
por: Pidoux, Guillaume, et al.
Publicado: (2015)

Proinflammatory and Immunoregulatory Roles of Eicosanoids in T Cells
por: Lone, Anna Mari, et al.
Publicado: (2013)

Targeting protein–protein interactions in complexes organized by A kinase anchoring proteins
por: Calejo, Ana I., et al.
Publicado: (2015)

Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells – Role of Anchored Protein Kinase A Signaling Units
por: Wehbi, Vanessa L., et al.
Publicado: (2016)

Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model
por: Christensen, S. T., et al.
Publicado: (2019)

Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
por: Kreyberg, Ina, et al.
Publicado: (2023)

A national intercalated medical student research program – student perceptions, satisfaction, and factors associated with pursuing a PhD
por: Sandvei, Marie Søfteland, et al.
Publicado: (2022)

Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma
por: Siegel, Matthew B., et al.
Publicado: (2015)

Spatiotemporal regulation of cAMP signaling controls the human trophoblast fusion
por: Gerbaud, Pascale, et al.
Publicado: (2015)

Comparison of [(18)F]fluciclovine and [(18)F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
por: Stokke, Caroline, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_59msmf1m7726dmd5gni8j3la1t